London patient with zip code for weight loss against weight loss medication

High -ranking doctors have warned that there are serious inequality for weight loss medication in London, so that patients are confronted with a postcode lottery that tries to access them.

Weight loss medication is administered through a weekly injection, and patients feel full for a long time and reduce their appetite and general food intake.

Dorottya Norton, an NHS weight management specialist, told a committee of the London assembly: “The lack of fairness is obvious for the patients -some can start and others cannot.”

Accordingly The local democracy reporting serviceInequality is growing when patients buy products online that are either fake or interpreted for medical research.

Tirepatide – also known as his brand name Mounjaro – has been prescribed for severe obese patients in Great Britain since June. Around 220,000 people with the “greatest need” to receive it in the next three years.

The NHS is regarded as an additional instrument to combat the growing obesity rate of the country and to reduce the entire workload of the health service.

However, high -ranking doctors and pharmacists have warned that there is serious inequality in London when accessing access to weight loss drugs.

Ms. Norton also told the health committee: “In London, England and Great Britain, there is a lack of durability – there is a zip code with weight management services.”

She added that there were “enormous increase” in recommendations.

“We need a certain degree of consistency in London so that patients can escape from the zip code.

“It becomes a difficult clinical environment because such a gap between what the patients understand what they want and what is available.

“Many patients are also self -financed, so inequality grows.”

An imbalance between supply and demand has prompted those who can afford not to secure regulated supplies on the black market, the committee was informed.

Sokratis Papafloratos, founder of Numan, an online provider of medication for weight reduction, said: “In terms of illegal access, I think that we really underestimate the problem and misunderstand it.

“You can buy the active ingredients as someone who researches.

“However, people find these companies and buy and import ingredients that are designed for clinical research and inject them into their bodies, which I am concerned.”

Sukhi Basra, deputy chair of the National Pharmacy Association, told the members of the London Assembly that their patients showed their photos of boxes “full of fake medication”.

“They are sold as generic medication, and that prescribes me.”